192 related articles for article (PubMed ID: 69667)
1. Regulation of the immune response to tumor antigens. III. Characterization of thymic suppressor factor(s) produced by tumor-bearing hosts.
Greene MI; Fujimoto S; Sehon AH
J Immunol; 1977 Aug; 119(2):757-64. PubMed ID: 69667
[TBL] [Abstract][Full Text] [Related]
2. Regualtion of the immune response to tumor antigens. I. Immunosuppressor cells in tumor-bearing hosts.
Fujimoto S; Greene MI; Sehon AH
J Immunol; 1976 Mar; 116(3):791-9. PubMed ID: 1082894
[TBL] [Abstract][Full Text] [Related]
3. Regulation of the immune response to tumor antigens. II. The nature of immunosuppressor cells in tumor-bearing hosts.
Fujimoto S; Greene MI; Sehon AH
J Immunol; 1976 Mar; 116(3):800-6. PubMed ID: 1254955
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a cloned ultraviolet radiation (UV)-induced suppressor T cell line that is capable of inhibiting anti-UV tumor-immune responses.
Roberts LK
J Immunol; 1986 Mar; 136(5):1908-16. PubMed ID: 2936813
[TBL] [Abstract][Full Text] [Related]
5. Regulation of the immune response to tumor antigen. IV. Tumor antigen-specific suppressor factor(s) bear I-J determinants and induce suppressor T cells in vivo.
Perry LL; Benacerraf B; Greene MI
J Immunol; 1978 Dec; 121(6):2144-7. PubMed ID: 82578
[TBL] [Abstract][Full Text] [Related]
6. Regulation of the immune response to tumor antigen. VI. Differential specificities of suppressor T cells or their products and effector T cells.
Greene MI; Perry LL
J Immunol; 1978 Dec; 121(6):2363-6. PubMed ID: 82582
[TBL] [Abstract][Full Text] [Related]
7. H-2 antigens and tumour-associated transplantation antigens in clones derived from a methylcholanthrene-induced BALB/c tumour: their influence on the generation in vitro and in vivo of the specific anti-tumour immune response.
Pérez M; Garrido A; Algarra I; Caballero A; Delgado C; Collado MD; Fernández-Cruz E; Garrido F
Exp Clin Immunogenet; 1989; 6(3):204-18. PubMed ID: 2631798
[TBL] [Abstract][Full Text] [Related]
8. Cell-mediated immune responses to syngeneic tumors. I. Identification of two distinct CTL effector pathways which differ in antigen specificity, genetic regulation, and cell surface phenotype.
Lynch DH; Daynes RA; Hodes RJ
J Immunol; 1986 Feb; 136(4):1521-7. PubMed ID: 2418117
[TBL] [Abstract][Full Text] [Related]
9. Investigations into the nature of Igh-V region-restricted T cell interactions by using antibodies to antigens on methylcholanthrene-induced sarcomas. I. Analysis of an Igh-V-restricted suppressor-inducer factor.
Flood PM
J Immunol; 1985 Mar; 134(3):1665-72. PubMed ID: 2578515
[TBL] [Abstract][Full Text] [Related]
10. Suppressor cells in tumor-bearing mice capable of nonspecific blocking of in vitro immunization against transplant antigens.
Eggers AE; Wunderlich JR
J Immunol; 1975 May; 114(5):1554-6. PubMed ID: 123545
[TBL] [Abstract][Full Text] [Related]
11. Biological and biochemical properties of Nonidet P40-solubilized and partially purified tumor-specific antigens of the transplantation type from plasma membranes of a methylcholanthrene-induced sarcoma.
Natori T; Law LW; Appella E
Cancer Res; 1977 Sep; 37(9):3406-13. PubMed ID: 69494
[TBL] [Abstract][Full Text] [Related]
12. Biochemical characterization of 1-butanol-extracted murine tumor-specific transplantation antigens.
LeGrue SJ; Pellis NR; Riley LB; Kahan BD
Cancer Res; 1985 Jul; 45(7):3164-72. PubMed ID: 2408745
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy of murine sarcomas with auto-anti-idiotypic monoclonal antibodies which bind to tumor-specific T cells.
Nelson KA; George E; Swenson C; Forstrom JW; Hellström KE
J Immunol; 1987 Sep; 139(6):2110-7. PubMed ID: 2957449
[TBL] [Abstract][Full Text] [Related]
14. Activation of suppressor cells by syngeneic tumor transplants in mice.
Argyris BF
Cancer Res; 1978 May; 38(5):1269-73. PubMed ID: 147732
[TBL] [Abstract][Full Text] [Related]
15. In vitro studies on the cellular immune response of tumor-bearing mice to SV40-transformed cells.
Blasecki JW; Tevethia SS
J Immunol; 1975 Jan; 114(1 Pt 1):244-9. PubMed ID: 163278
[TBL] [Abstract][Full Text] [Related]
16. Common transplantation antigens on methylcholanthrene-induced murine sarcomas detected by three assays of tumor rejection.
Leffell MS; Coggin JH
Cancer Res; 1977 Nov; 37(11):4112-9. PubMed ID: 908044
[No Abstract] [Full Text] [Related]
17. Evidence for the functional binding in vivo of tumor rejection antigens to antigen-presenting cells in tumor-bearing hosts.
Shimizu J; Zou JP; Ikegame K; Katagiri T; Fujiwara H; Hamaoka T
J Immunol; 1991 Mar; 146(5):1708-14. PubMed ID: 1993850
[TBL] [Abstract][Full Text] [Related]
18. Suppression of cell-mediated antitumor immunity by complete Freund's adjuvant.
Koyama S; Yoshioka T; Sakita T
Cancer Res; 1982 Aug; 42(8):3215-9. PubMed ID: 6980047
[TBL] [Abstract][Full Text] [Related]
19. The role of tumor-specific Lyt-1+2- T cells in eradicating tumor cells in vivo. I. Lyt-1+2- T cells do not necessarily require recruitment of host's cytotoxic T cell precursors for implementation of in vivo immunity.
Fujiwara H; Fukuzawa M; Yoshioka T; Nakajima H; Hamaoka T
J Immunol; 1984 Sep; 133(3):1671-6. PubMed ID: 6205091
[TBL] [Abstract][Full Text] [Related]
20. Regulation of cell-mediated immunologic reactivity to Moloney Murine sarcoma virus-induced tumors. III. Further characterization of tumor-specific serum blocking factors.
Halliday WJ; Koppi TA; McKenzie IF
J Natl Cancer Inst; 1982 Oct; 69(4):939-44. PubMed ID: 6750199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
